Trial intelligence / Profile preview

BMS-770767 in Primary Hypercholesterolemia

NCT01058083Phase 2Completed

Sponsor
Bristol Myers Squibb
Start
May 2010
Primary completion
Mar 2011
Modality
Small Molecules
Countries
3
01

Overview

A Phase 2 trial of BMS-770767 in hypercholesterolemia, sponsored by Bristol Myers Squibb. Started May 2010; status: completed.

02

Drugs

BMS-770767
03

Conditions

hypercholesterolemia

Beyond the preview

Go deeper on NCT01058083.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01058083.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call